Body Protective Compound
The 15-residue linear sequence contains no cysteine residues, no disulfide constraints, and no unnatural amino acids, yet it maintains stability under conditions that would degrade nearly any other peptide of comparable size
Therefore, we are finalizing our proposal to amend 425.605(h)(1) to include an additional criterion, applicable for agreement periods beginning on or after January 1, 2027, under which we will require an ACO to have at least 5,000 assigned beneficiaries in each of its BYs to be eligible for the increased opportunities to share in savings, under the policy established at 425.605(h)
Its about more than just adding water to powder
Seventeen studies were conducted in hospital settings, and the remaining 8 in university hospital settings
Specifically, as discussed in the CY 2025 PFS final rule, Medicare CQM measures are eligible for flat benchmarks from performance year 2025 to performance year 2028 (89 FR 98121)